Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 4, 2020

Primary Completion Date

August 17, 2020

Study Completion Date

August 17, 2020

Conditions

Severe Acute Respiratory Syndrome Coronavirus 2

Interventions

BIOLOGICAL

COVID-19 convalescent plasma

Trial Locations (1)

Hospital Clínico Universidad Católica, Santiago

All Listed Sponsors

collaborator

Fundacion Arturo Lopez Perez

OTHER

lead

Pontificia Universidad Catolica de Chile

OTHER

NCT04375098 - Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection | Biotech Hunter | Biotech Hunter